Phase 3 Paracetamol Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

The NACSTOP 2 trial: Investigation of the early cessation of N-acetylcysteine in patients following paracetamol overdose.

paracetamol overdose

Monash Health200 enrolled6 locationsACTRN12619001549112

Recruiting

Phase 3

Double NAC trial: Investigation of increased N-acetylcysteine dosing in patients treated for paracetamol overdose.

paracetamol overdose

Monash Health230 enrolled6 locationsACTRN12619001548123